Pomona Ricera
Pomona Ricerca is a private Italian R&D biotech company dedicated to pioneering solutions for critical infectious diseases such as HCV, HIV, Influenza A, and JC virus. The company focuses on advancing research in monoclonal antibodies for prevention and treatment, providing tailored recombinant proteins and antibodies, and offering pre-clinical characterization services. Their mission is to improve patient outcomes and enhance quality of life through effective immunotherapeutic solutions.
Industries
Nr. of Employees
small (1-50)
Pomona Ricera
Products
GRE1
Human monoclonal antibody targeting a JCV VP1 conformational epitope; validated in ELISA, immunofluorescence, native Western blot and neutralization assays. Datasheet available.
e137
Monoclonal antibody recognizing an HCV E2 conformational epitope; validated in ELISA, immunofluorescence, native Western blot and neutralization assays. Datasheet available.
GRE1
Human monoclonal antibody targeting a JCV VP1 conformational epitope; validated in ELISA, immunofluorescence, native Western blot and neutralization assays. Datasheet available.
e137
Monoclonal antibody recognizing an HCV E2 conformational epitope; validated in ELISA, immunofluorescence, native Western blot and neutralization assays. Datasheet available.
Services
Generation, characterization and engineering of monoclonal antibodies from various source species; selection of optimal antibody format for the intended application.
Recombinant protein expression using mammalian and bacterial systems with purification and optional modifications to meet experimental specifications.
Commercial distribution of validated neutralizing antibodies and recombinant viral antigens for research use, including global shipping and order support.
Consultation to define project requirements, design a development plan and provide ongoing communication throughout antibody or protein projects.
Preparation and commercial transfer of pre-clinical antibody assets to partners via licensing agreements after pre-clinical characterization.
Generation, characterization and engineering of monoclonal antibodies from various source species; selection of optimal antibody format for the intended application.
Recombinant protein expression using mammalian and bacterial systems with purification and optional modifications to meet experimental specifications.
Commercial distribution of validated neutralizing antibodies and recombinant viral antigens for research use, including global shipping and order support.
Consultation to define project requirements, design a development plan and provide ongoing communication throughout antibody or protein projects.
Preparation and commercial transfer of pre-clinical antibody assets to partners via licensing agreements after pre-clinical characterization.
Expertise Areas
- Monoclonal antibody discovery
- Antibody engineering and formatting
- Pre-clinical characterization of biologics
- Recombinant protein expression and purification
Key Technologies
- Hybridoma technology
- Phage display
- Mammalian expression systems
- Bacterial expression systems
News & Updates
Discussion on the potential of monoclonal antibodies in medicine.
Recent increase in HMPV cases in China and global monitoring efforts.
Discussion on the importance of vaccination amidst the resurgence of measles.
Estimates of flu vaccine effectiveness and importance of vaccination.
Discussion on the potential of monoclonal antibodies in medicine.
Recent increase in HMPV cases in China and global monitoring efforts.
Discussion on the importance of vaccination amidst the resurgence of measles.
Estimates of flu vaccine effectiveness and importance of vaccination.